- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00347711
Bevacizumab and Retinal Vascular Occlusions
July 3, 2006 updated by: Asociación para Evitar la Ceguera en México
To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
D.F. Mexico
-
Mexico, D.F. Mexico, Mexico, 04030
- Recruiting
- Asociación Para Evitar la Ceguera en México
-
Contact:
- Griselda Alvarez, Fellow
- Phone Number: 1171 5255 10841400
- Email: retinamex@yahoo.com.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography
Exclusion Criteria:
- Previous surgery
- Uveitis
- Glaucoma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Griselda Alvarez, Fellow, Asociación Para Evitar la Ceguera en México
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
June 30, 2006
First Submitted That Met QC Criteria
July 3, 2006
First Posted (Estimate)
July 4, 2006
Study Record Updates
Last Update Posted (Estimate)
July 4, 2006
Last Update Submitted That Met QC Criteria
July 3, 2006
Last Verified
June 1, 2006
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- APEC-0020
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Occlusion
-
London Health Sciences CentreCompletedVascular Occlusion TestCanada
-
Tissue Regenix LtdCompletedPeripheral Arterial Vascular OcclusionHungary, Netherlands
-
IGLESIAS Juan FernandoUniversity of BernRecruitingVascular Access Site OcclusionSwitzerland, Greece, Italy, Belgium
-
Biruni UniversityIstanbul University - Cerrahpasa (IUC)CompletedExercise | Vascular Occlusion | Soccer | EMGTurkey
-
Shanghai Zhongshan HospitalUnknownVascular Access Complication | Vascular Access Site Occlusion | Vascular Access Malfunction
-
University of TorontoOntario Research FundUnknownCentral Retinal Vein Occlusion | Branch Retinal Vein Occlusion | Central Retinal Artery Occlusion | Branch Retinal Artery OcclusionCanada
-
hui houUnknownLaparoscopic Liver Resection | Vascular Occlusion | TourniquetChina
-
Oslo University HospitalRecruitingCentral Retinal Artery OcclusionDenmark, Norway, Belgium, Sweden, Finland, Ireland, Lithuania, Australia, Austria
-
Xinhua Hospital, Shanghai Jiao Tong University...RecruitingSafety and Efficacy After Selective Intra-arterial Thrombolysis for Central Retinal Artery OcclusionCentral Retinal Artery OcclusionChina
-
Asociación para Evitar la Ceguera en MéxicoUnknownCentral Retinal Artery OcclusionMexico
Clinical Trials on Intravitreal injection
-
Jeffrey S HeierKato Pharmaceuticals, Inc.CompletedVitreomacular Traction | Vitreomacular Adhesion | Vitreomacular AttachmentUnited States
-
Indonesia UniversityBayerCompletedDiabetic Retinopathy | Diabetic Macular Edema | Clinically Significant Macular EdemaIndonesia
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityCompletedNeovascular GlaucomaChina
-
Afyonkarahisar Health Sciences UniversityCompleted
-
Hemera BiosciencesWithdrawnGeographic Atrophy | Dry Age-related Macular Degeneration | Gene Therapy | Intravitreal Injection
-
Peregrine Eye and Laser InstituteCompletedDiabetic Macular Edema | Choroidal Neovascularization | Neovascular Age-related Macular Degeneration | Uveitic Macular Edema | Retinal Vein Occlusion With Macular EdemaPhilippines
-
Eye & ENT Hospital of Fudan UniversityUnknownDiabetic Retinopathy | Diabetic Macular Edema | Cataract Diabetic
-
Benha UniversityRecruiting
-
Xun XuPeking University; Zhongshan Ophthalmic Center, Sun Yat-sen University; Air Force... and other collaboratorsUnknownAge-Related Macular Degeneration | Polypoidal Choroidal Vasculopathy | Pathological Myopia | Conbercept | PharmacogenomicChina
-
Chengdu Kanghong Biotech Co., Ltd.Beijing DMS Pharma Ltd.; The Digital Angiography Reading Center (DARC)CompletedNeovascular Age-related Macular DegenerationChina